We are monitoring the impact of COVID-19 on APAC Nanomedicine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6252
Share on
Share on

Asia Pacific Nanomedicine Market Research Report - Segmented By Product, By Disease Type, By Nanomolecule Type & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: February, 2020
ID: 6252
Pages: 145

APAC Nanomedicine Market Size & Growth (2019 – 2024)

As per the research report, the size of the Asia Pacific Nanomedicine Market is valued at USD 22.67 billion in 2019 and is projected to grow at a CAGR of 16.3%, to reach USD 48.24 billion by 2024 during the forecast period 2019-2024. 

The application of various techniques and instruments of nanotechnology in the field of medicine is known as Nanomedicine. It involves using nanoscale materials to diagnose diseases, drug delivery and other functions. Nanomedicine has the potential to revolutionize medicine in the future.

One of the major challenges for the use of nanoparticles in medicine is to make the materials as biocompatible. Applications of nanocapsules in drug delivery have shown excellent results in chemotherapy. Nanomedicine enables great precision in both diagnostics and therapeutics which is not possible before. Pipeline products which are being developed with the intention to target cancerous tumors are expected to boost the nanomedicine market.

Increasing applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems, growing number of cancer and cardiovascular diseases, increasing public and private investments on research activities in nanomedicine and advancements in the biodegradable nanoparticles are the major factors propelling the growth of nanomedicine market. However, unfavorable approval processes possibility for unintended risks during therapies and high cost of treatment using nanomedicine are hindering the market growth.

This research report segmented and sub-segmented into the following categories:

  • By Product: Diagnostic Imaging, Regenerative Medicine, Drug Delivery, Implants, Vaccines And Others
  • By Disease Type: Cardiovascular Diseases, Neurological Diseases, Ophthalmological Diseases, Infectious Diseases, Immunological Diseases, Orthopedic Disorders, Oncological Diseases And Others
  • By Nanomolecule Type: Nanotubes, Nanoparticles, Nanodevices, Nanoshells And Others
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

There is a high incidence of cancer and cardiovascular diseases in Asia pacific due to the large geriatric population in this region. Growing health awareness and increasing healthcare expenditure are also driving the market growth. China leads the nanomedicine market in this region.

The Top companies leading in the APAC Nanomedicine Market profiled in the report are Johnson & Johnson, Merck & Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc, Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead Pharmaceuticals.

1. Introduction          

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation                       

                5.1 Product 

                                5.1.1 Introduction                                           

                                5.1.2 Diagnostic Imaging                                               

                                5.1.3 Regenerative Medicine                                     

                                5.1.4 Drug Delivery                                         

                                5.1.5 Implants                                   

                                5.1.6 Vaccines                                   

                                5.1.7 Others                                      

                                5.1.8  Y-o-Y Growth Analysis, By Product                                              

                                5.1.9  Market Attractiveness Analysis, By Product                                            

                                5.1.10  Market Share Analysis, By Product                                            

                5.2 Disease Type      

                                5.2.1 Introduction                                           

                                5.2.2 Cardiovascular Diseases                                    

                                5.2.3 Neurological Diseases                                        

                                5.2.4 Ophthalmological Diseases                                              

                                5.2.5 Infectious Diseases                                             

                                5.2.6 Immunological Diseases                                    

                                5.2.7 Orthopedic Disorders                                         

                                5.2.8 Oncological Diseases                                           

                                5.2.9 Others                                      

                                5.2.10 Y-o-Y Growth Analysis, By Disease Type                                  

                                5.2.11 Market Attractiveness Analysis, By Disease Type                                                

                                5.2.12 Market Share Analysis, By Disease Type                                  

                5.3 Nanomolecule Type        

                                5.3.1 Introduction                                           

                                5.3.2 Nanotubes                                              

                                5.3.3 Nanoparticles                                        

                                5.3.4 Nanodevices                                          

                                5.3.5 Nanoshells                                              

                                5.3.6 Others                                      

                                5.3.7 Y-o-Y Growth Analysis, By Nanomolecule Type                                       

                                5.3.8  Market Attractiveness Analysis, By Nanomolecule Type                                    

                                5.3.9  Market Share Analysis, By Nanomolecule Type                                     

6. Geographical Analysis                       

                6.1 Introduction        

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Disease Type                

                                                6.1.3.4 By Nanomolecule Type                  

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Disease Type                

                                                6.1.4.4 By Nanomolecule Type                  

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Disease Type                

                                                6.1.5.4 By Nanomolecule Type                  

                6.2 China      

                6.3 India       

                6.4 Japan     

                6.5 South Korea        

                6.6 Australia      

7. Strategic Analysis                

                7.1 PESTLE analysis  

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis       

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                 

                8.1 Johnson & Johnson 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Merck & Co                                                

                8.3 Pfizer     

                8.4 Abbott Laboratories        

                8.5 GE Healthcare    

                8.6 Celgene Corporation       

                8.7 Nanosphere, Inc      

                8.8 Gilead Sciences  

                8.9 Hoffmann-La Roche

                8.10 Nanospectra Biosciences   

                8.11 Arrowhead Pharmaceuticals      

9. Competitive Landscape                    

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10. Market Outlook and Investment Opportunities                  

Appendix                    

                a) List of Tables

                b) List of Figures       

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product Type, by Disease type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Asia Pacific Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  2. Asia Pacific Diagnostic Imaging Market By Region, From 2019-2024 ( USD Billion )
  3. Asia Pacific Regenerative Medicine Market By Region, From 2019-2024 ( USD Billion )
  4. Asia Pacific Drug Delivery Market By Region, From 2019-2024 ( USD Billion )
  5. Asia Pacific Implants Market By Region, From 2019-2024 ( USD Billion )
  6. Asia Pacific Vaccines Market By Region, From 2019-2024 ( USD Billion )
  7. Asia Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  8. Asia Pacific Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  9. Asia Pacific Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Billion )
  10. Asia Pacific Neurological Diseases Market By Region, From 2019-2024 ( USD Billion )
  11. Asia Pacific Ophthalmological Diseases Market By Region, From 2019-2024 ( USD Billion )
  12. Asia Pacific Infectious Diseases Market By Region, From 2019-2024 ( USD Billion )
  13. Asia Pacific Immunological Diseases Market By Region, From 2019-2024 ( USD Billion )
  14. Asia Pacific Orthopedic Disorders Market By Region, From 2019-2024 ( USD Billion )
  15. Asia Pacific Oncological Diseases Market By Region, From 2019-2024 ( USD Billion )
  16. Asia Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  17. Asia Pacific Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  18. Asia Pacific Nanotubes Market By Region, From 2019-2024 ( USD Billion )
  19. Asia Pacific Nanoparticles Market By Region, From 2019-2024 ( USD Billion )
  20. Asia Pacific Nanodevices Market By Region, From 2019-2024 ( USD Billion )
  21. Asia Pacific Nanoshells  Market By Region, From 2019-2024 ( USD Billion )
  22. Asia Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  23. Japan Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  24. Japan Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  25. Japan Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  26. China Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  27. China Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  28. China Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  29. India Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  30. India Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  31. India Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  32. Australia Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  33. Australia Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  34. Australia Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )
  35. South Korea Nanomedicine Market By Product, From 2019-2024 ( USD Billion )
  36. South Korea Nanomedicine Market By Disease Type, From 2019-2024 ( USD Billion )
  37. South Korea Nanomedicine Market By Nanomolecule Type, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample